Equillium
34 hedge funds and large institutions have $44.4M invested in Equillium in 2020 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 9 closing their positions.
320% more capital invested
Capital invested by funds: $10.6M → $44.4M (+$33.8M)
133% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 9
55% more funds holding
Funds holding: 22 → 34 (+12)
50% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 4
11.46% more ownership
Funds ownership: 20.28% → 31.73% (+11%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SB
Samsara BioCapital
Palo Alto,
California
|
+$8.7M |
| 2 |
RI
RTW Investments
New York
|
+$8.14M |
| 3 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$5.67M |
| 4 |
Franklin Resources
San Mateo,
California
|
+$5.67M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$5.07M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.96M |
| 2 |
Goldman Sachs
New York
|
-$1.39M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
-$792K |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$284K |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
-$174K |
EQ Hedge Fund Activity: Q3 2020 in Review
34 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Equillium (EQ) for Q3 2020, worth a combined $44.4M — up 320% from $10.6M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new EQ positions and 9 closed out — a net gain of 12 holders — while 6 added to existing stakes and 4 trimmed.
The largest buyer was Samsara BioCapital, opening a new position worth an estimated $8.7M. The largest seller was Fidelity Investments, cutting an estimated $1.96M.
- 34 institutional investors held Equillium (EQ) as of Q3 2020, up from 22 in Q2 2020.
- Funds reported $44.4M of Equillium stock for Q3 2020, up 320% quarter-over-quarter.
- 21 funds opened new Equillium positions in Q3 2020 and 9 closed out, a net change of +12 holders.
- The largest Equillium buyer in Q3 2020 was Samsara BioCapital, an estimated $8.7M added.
- The largest Equillium seller in Q3 2020 was Fidelity Investments, an estimated $1.96M sold.
Based on aggregated 13F filings for Q3 2020.